Gadolinium-based contrast agents (GBCAs) are considered to be safe, although sometimes patients report a hypersensitivity reaction when undergoing magnetic resonance imaging (MRI). The mechanisms of these reactions and of the sensitization to GBCAs are still largely unknown. We describe four cases of patients who experienced immediate adverse reactions to GBCAs with a demonstrated cutaneous hypersensitivity suggesting an IgE-mediated mechanism.
Nucera, E., Urbani, S., Buonomo, A., De Pasquale, T. M. A., Rizzi, A., Aruanno, A., Pucci, S., Gadolinium-based contrast agents hypersensitivity: A case series, <<JOURNAL OF ASTHMA AND ALLERGY>>, 2021; 14 (15): 241-244. [doi:10.2147/JAA.S295748] [http://hdl.handle.net/10807/177962]
Gadolinium-based contrast agents hypersensitivity: A case series
Nucera, Eleonora;Urbani, Sara;Buonomo, Alessandro;De Pasquale, Tiziana Maria Angela;Rizzi, Angela;
2021
Abstract
Gadolinium-based contrast agents (GBCAs) are considered to be safe, although sometimes patients report a hypersensitivity reaction when undergoing magnetic resonance imaging (MRI). The mechanisms of these reactions and of the sensitization to GBCAs are still largely unknown. We describe four cases of patients who experienced immediate adverse reactions to GBCAs with a demonstrated cutaneous hypersensitivity suggesting an IgE-mediated mechanism.
| File | Dimensione | Formato | |
|---|---|---|---|
|
gadoli.pdf
accesso aperto
Tipologia file ?:
Versione Editoriale (PDF)
Note: https://creativecommons.org/licenses/by-nc/3.0/
Licenza:
Creative commons
Dimensione
303.01 kB
Formato
Adobe PDF
|
303.01 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
